http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101897004-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_849b873488ec2cdb529cf36a6ecee3a8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-0883
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-08
filingDate 2017-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c3488c5eef3033eba6033ae1e61d94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69282917018c3020d11932f96f48f1ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4f5bd537f5c335754e8049fb6c9d68
publicationDate 2018-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101897004-B1
titleOfInvention An echocardiographic time-course efficiency evaluation method for drugs of cardiovascular disease
abstract The present invention relates to a method for evaluating echocardiography for the efficacy of a cardiovascular drug. The method according to the present invention is based on a change in cardiac function over time in a rat myocardial infarction model. In particular, the myocardial infarction model is based on the observation that recovery of cardiac contractility is observed with time, but recovery of cardiac relaxation performance is not observed. The present invention provides a method for the treatment of cardiovascular disease, comprising: preparing an animal model of cardiovascular disease; Administering the drug to be evaluated to the drug administration group by dividing the animal model into a control group and a drug administration group; Performing echocardiography on the control group and the drug administration group; Observing changes in cardiac function over time in the echocardiography; And evaluating the drug by weighting the evaluation factor of relaxation and the evaluation of the effect of the cardiovascular drug on the evaluation of cardiovascular drug efficacy &Lt; / RTI &gt;
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200067413-A
priorityDate 2017-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011097850-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160021803-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9870652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420501442

Total number of triples: 21.